Laboratorio Reig Jofre, S.A. (FRA:FEQ1)

Market Cap	223.82M +9.2%
Revenue (ttm)	330.34M -1.0%
Net Income	4.25M -55.5%
EPS	0.05
Shares Out	n/a
PE Ratio	52.66
Forward PE	101.74
Dividend	0.04 (1.50%)
Ex-Dividend Date	May 15, 2025

Volume	n/a
Average Volume	476
Open	2.680
Previous Close	2.640
Day's Range	2.640 - 2.680
52-Week Range	2.430 - 3.250
Beta	n/a
RSI	56.09
Earnings Date	Feb 27, 2026

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmacy, food, and animal food. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; and food supplements und...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1929
• Employees: 1,426
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: FEQ1

Financial Performance

In 2024, Laboratorio Reig Jofre's revenue was 341.37 million, an increase of 7.36% compared to the previous year's 317.95 million. Earnings were 10.38 million, an increase of 10.36%.